DEMANT Share Price Performance
DKK 0
-260.80 (-100.00%)
Price DKK 0
Fair ValueDKK 232.17
Share Pricen/a
Demant A/S Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 14 Fair Values set on narratives written by author
DEMANT Community Narratives
AN
Fair Value DKK 232.17 19.4% undervalued intrinsic discount
DEMANT: Rising Share Buybacks Will Drive Medium-Term Upside Momentum
0users have liked this narrative
0users have commented on this narrative
6users have followed this narrative
AN
Fair Value DKK 195 4.0% undervalued intrinsic discount
Lower ASPs And Slower Margin Recovery Will Pressure Earnings In Coming Years
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value DKK 316 40.8% undervalued intrinsic discount
Global Hearing Care Underpenetration And AI Signal Processing Will Drive Significant Upside Potential
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
DEMANT: Rising Share Buybacks Will Drive Medium-Term Upside Momentum
Key Takeaways Rising hearing health awareness and reduced stigma, combined with demographic trends, are expected to boost long-term demand and support recovery in revenues. Investment in advanced products and retail expansion positions Demant for premium market share, scalable service revenues, and enhanced profitability as conditions improve.Read more
103
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
6users have followed this narrative
AN
DKK 232.17
19.4% undervalued intrinsic discount
AnalystConsensusTarget's Fair Value
Revenue
7.83% p.a.
Profit Margin
11.86%
Future PE
17.32x
Price in 2029
DKK 283.29
Lower ASPs And Slower Margin Recovery Will Pressure Earnings In Coming Years
Catalysts About Demant Demant develops and sells hearing aids, hearing care retail services and diagnostic equipment for hearing health. What are the underlying business or industry changes driving this perspective?Read more
7
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
DKK 195
4.0% undervalued intrinsic discount
AnalystLowTarget's Fair Value
Revenue
5.97% p.a.
Profit Margin
12.87%
Future PE
14.1x
Price in 2029
DKK 235.2
Global Hearing Care Underpenetration And AI Signal Processing Will Drive Significant Upside Potential
Catalysts About Demant Demant develops and sells advanced hearing aids, hearing care services and diagnostic equipment worldwide. What are the underlying business or industry changes driving this perspective?Read more
5
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
DKK 316
40.8% undervalued intrinsic discount
AnalystHighTarget's Fair Value
Revenue
10.17% p.a.
Profit Margin
13.87%
Future PE
18.85x
Price in 2028
DKK 381
Trending Discussion
Recently Updated Narratives
AN
DEMANT: Recent Rating Upgrade May Support Future Upside Despite Softer Margins
Fair Value: DKK 232.17 19.4% undervalued intrinsic discount
6 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Lower ASPs And Slower Margin Recovery Will Pressure Earnings In Coming Years
Fair Value: DKK 195 4.0% undervalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Global Hearing Care Underpenetration And AI Signal Processing Will Drive Significant Upside Potential
Fair Value: DKK 316 40.8% undervalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Demant A/S Key Details
Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
Aug 11, 2026
- 11.23
- 75.62%
- 10.31%
- 177.5%
About DEMANT
- Founded
- 1904
- Employees
- 25077
- CEO
- WebsiteView website
Demant A/S operates as a hearing healthcare company in Europe, North America, Asia, Pacific region, and internationally. It engages in the development, manufacture, and wholesale of hearing aids; owning and operating hearing care clinics; and offers hearing and balance assessment solutions used by audiologists, ENT doctors, and balance clinics. The company was formerly known as William Demant Holding A/S and changed its name to Demant A/S in March 2019. Demant A/S was founded in 1904 and is headquartered in Smørum, Denmark.
